Influenza Vaccine in Lung Transplant Patients - Seroprotection
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This a sub-study of a 5-year study designed to investigate how antibody and T cell responses
following influenza vaccine compare among lung transplant patients, patients waiting for lung
transplantation, and healthy individuals.
This study is designed to investigate two different definitions of influenza vaccine
seroprotection at mid-season in lung transplant patients.